NCT07508059 High Resolution Pharyngeal Manometry (HRPM) Biofeedback
| NCT ID | NCT07508059 |
| Status | Recruiting |
| Phase | — |
| Sponsor | NYU Langone Health |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-08-19 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-08-19 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to quantify the added benefit of visual biofeedback from High Resolution Pharyngeal Manometry (HRPM) for swallowing rehabilitation. Primary aims including assessing changes in swallowing biomechanics (pressure generation, timing) during swallow maneuvers with and without HRPM visual biofeedback. Secondary aim includes participant attitudes related to visual biofeedback and the experience of HRPM.
Eligibility Criteria
Inclusion Criteria: 1. Participants must be independent community dwelling adults. 2. Participants must be between the ages of 18-40 years old. 3. Willingness to consent and participate in the study procedures. 4. No reported dysphagia or difficulty swallowing evidenced by an EAT-10 Score \<3. Exclusion Criteria: 1. Known structural or neurological causes of dysphagia (e.g., stroke, brain injury, or head/neck cancer). 2. Recent or remote history of swallowing therapy; familiarity with swallowing maneuvers from relevant coursework as applicable (i.e., speech language pathology students).
Contact & Investigator
Sonja Molfenter
PRINCIPAL INVESTIGATOR
NYU Langone Health
Frequently Asked Questions
Who can join the NCT07508059 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07508059 currently recruiting?
Yes, NCT07508059 is actively recruiting participants. Contact the research team at Smm16@nyu.edu for enrollment information.
Where is the NCT07508059 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07508059 clinical trial?
NCT07508059 is sponsored by NYU Langone Health. The principal investigator is Sonja Molfenter at NYU Langone Health. The trial plans to enroll 50 participants.